Bridging the gaps: the gut-lung axis and microbial metabolites in the pathogenesis and treatment of pulmonary fibrosis

Pulmonary fibrosis (PF) is a chronic interstitial lung disease characterized by structural damage to the lung parenchyma, excessive deposition of extracellular matrix (ECM), and irreversible decline in lung function. Current pharmacological treatments cannot effectively reverse fibrosis, highlightin...

תיאור מלא

מידע ביבליוגרפי

Principais autores:	Yingxu Wu, Hao Yan, Pin Li, Yongming Liu, Jiapeng Leng, Yuwei Cui, Xiaodong Lv, Lijian Pang, Ningzi Zang
פורמט:	Artigo
שפה:	Inglês
יצא לאור:	Frontiers Media S.A. 2026-04-01
סדרה:	Frontiers in Medicine
נושאים:	gut microbiome gut microbiota gut-lung axis microbial metabolites pulmonary fibrosis
גישה מקוונת:	https://www.frontiersin.org/articles/10.3389/fmed.2026.1817835/full
תגים:	הוספת תג אין תגיות, היה/י הראשונ/ה לתייג את הרשומה!